SCHEMBL26152005

SCHEMBL26152005

COC(=O)c1cnc2c(c1)OCC2(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 2/20 0.44
RARG P13631 2/20 0.44
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ATM Q13315 1/20 0.40
PSMD14 O00487 1/20 0.37
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
RARA P10276 1/20 0.36
CYP3A4 P08684 3/20 0.34
CYP26A1 O43174 2/20 0.34
SPR P35270 1/20 0.34
ROCK2 O75116 1/20 0.34
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30445637 1.00 RARB (0.44) RARBRARGMAPK1KDM4EL3MBTL1
SCHEMBL30445521 0.86 RARB (0.46) RARBRARGMAPK1KDM4EL3MBTL1
SCHEMBL26154767 0.86 RARB (0.46) RARBRARGMAPK1KDM4EL3MBTL1
SCHEMBL30445352 0.84 RARB (0.41) RARBRARGMAPK1KDM4EALDH1A1
SCHEMBL26152006 0.84 RARB (0.41) RARBRARGMAPK1KDM4EALDH1A1
SCHEMBL30133968 0.75 MAPK1 (0.41) RARBRARGMAPK1KDM4EL3MBTL1
SCHEMBL31525543 0.74 HTR2B (0.35) MAPK1KDM4ECASP3SENP7ALDH1A1
SCHEMBL1018779 0.74 RARB (0.58) RARBRARGKDM4EATMNPC1
SCHEMBL28545626 0.72 LMNA (0.49) RARBRARGKDM4EL3MBTL1NPC1
SCHEMBL16744298 0.71 RARB (0.73) RARBRARGMAPK1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118251389-A Pyridyl derivatives as sodium channel activators 泽农医药公司 2024-06-25 CN disclosed
US-20230150972-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2023-05-18 US disclosed
US-20230150972-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150972-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS SCN1B, SCN1A, SCN2B RARB 1342/4885RARG 2703/4885MAPK1 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.